Cas no 376348-65-1 (Maraviroc)

Maraviroc structure
Maraviroc structure
Product Name:Maraviroc
CAS No:376348-65-1
MF:C29H41F2N5O
MW:513.665553808212
MDL:MFCD13188530
CID:67929
PubChem ID:3002977
Update Time:2025-04-18

Maraviroc Chemical and Physical Properties

Names and Identifiers

    • Maraviroc
    • Maraviroc(UK427857)
    • 4,4-Difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide
    • maroviroc
    • 4,4-Difluoro-N-{(1S)-3-[3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl}cyclohexanecarboxamide
    • Maraviroc(Selzentry)
    • 4,4-difluoro-N-[(1S)-3-[(1R,3R,5S)-3-[3-Methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxaMide
    • Celsentri
    • 4,4-Difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]cyclohexanecarboxamide
    • UK-427857
    • UK 427857
    • Aristada
    • Selzentry
    • MD6P741W8A
    • MVC
    • Cyclohexanecarboxamide, 4,4-difluoro-N-((1S)-3-((3-exo)-3-(3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)oct-8-yl)-1-phenylpropyl)-
    • Isopropyl, 4,4-difluoro-N-((1S)-3-{(1R,3s,5S)-3-(3-methyl-5-(prop
    • J-521678
    • Maraviroc, endo-
    • MLS006011960
    • MARAVIROC [WHO-DD]
    • HY-13004
    • maravirocum
    • MARAVIROC [INN]
    • 4,4-difluoro-N-[(1S)-3-[(1S,5R)-3-(3-isopropyl-5-methyl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenyl-propyl]cyclohexanecarboxamide
    • Cyclohexanecarboxamide,4,4-difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]-
    • Celsentri(TM)
    • Maraviroc, >=98% (HPLC)
    • AKOS032946723
    • Isopropyl, 4,4-difluoro-N-((1S)-3-{(1R,3s,5S)-3-(3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)octan-8-yl}-1-phenylpropyl)cyclohexanecarboxamide
    • 4,4-Difluoro-N-((S)-3-((1R,3R,5S)-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl)-1-phenylpropyl)cyclohexane-1-carboxamide
    • 4,4-difluoro-N-((1S)-3-((1R,5S)-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl)-1-phenylpropyl)cyclohexane-1-carboxamide
    • [3H]maraviroc
    • CAS-376348-65-1
    • DB04835
    • EN300-22828861
    • CHEMBL256907
    • DTXSID8048949
    • MARAVIROC [MART.]
    • MARAVIROC [VANDF]
    • EN300-7367238
    • SCHEMBL4576508
    • MARAVIROC [MI]
    • BRD-A23284911-001-02-4
    • GSNHKUDZZFZSJB-HLMSNRGBSA-N
    • 4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-isopropyl-5-methyl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenyl-propyl]cyclohexanecarboxamide
    • AKOS032960315
    • SR-01000942244
    • 4,4-Difluoro-N-[(1S)-3-[(3-endo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]cyclohexanecarboxamide
    • 4,4-Difluoro-N-[(1S)-3-[(1R,5S)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboximidic acid
    • 4,4-Difluoro-cyclohexanecarboxylic acid {(S)-3-[(1S,5S)-3-(3-isopropyl-5-methyl-[1,2,4]triazol-4-yl)-8-aza-bicyclo[3.2.1]oct-8-yl]-1-phenyl-propyl}-amide
    • A3C7SRV8DV
    • Rel-Maraviroc
    • DTXCID5028875
    • CHEMBL584744
    • MARAVIROC [EMA EPAR]
    • CHEMBL1201187
    • BDBM50583789
    • Cyclohexanecarboxamide, 4,4-difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]-
    • AS-75265
    • 4,4-difluoro-N-((S)-3-(3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-aza-bicyclo[3.2.1]octan-8-yl)-1-phenylpropyl)cyclohexanecarboxamide
    • 4,4-difluoro-N-[(1S)-3-[(1R,3S,5S)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide
    • 4,4-diluoro-N-[(1S)-3-[(1S,5R)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide
    • SCHEMBL51991
    • BDBM50464147
    • CHEBI:184662
    • MRV
    • UK-427,857
    • 4,4-Difluoro-N-[(1s)-3-{(3-Exo)-3-[3-Methyl-5-(Propan-2-Yl)-4h-1,2,4-Triazol-4-Yl]-8-Azabicyclo[3.2.1]oct-8-Yl}-1-Phenylpropyl]cyclohexanecarboxamide
    • [3H]UK-427,857
    • PRO 140 & Maraviroc
    • NCGC00183109-02
    • AC-558
    • MARAVIROC [JAN]
    • Tox21_113369
    • BDBM50334986
    • Maraviroc [INN:BAN:JAN]
    • Cyclohexanecarboxamide, 4,4-difluoro-N-[(1S)-3-[(3-endo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]-
    • Selzentry(TM)
    • exo-4,4-Difluoro-N-[3-[3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1(S)-phenylpropyl]cyclohexanecarboxamide
    • 376348-65-1
    • EN300-128501
    • Z1614451557
    • AKOS025402143
    • GSNHKUDZZFZSJB-QUMGSSFMSA-N
    • AMY12578
    • CS-0366
    • SR-01000942244-1
    • EX-A200
    • 4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide
    • MFCD13188530
    • Q421369
    • [3H]UK 427,857
    • SCHEMBL2177194
    • PRO 140 (Anti-CCR5 monoclonal antibody) & exo-4,4-Difluoro-N-[3-[3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1(S)-phenylpropyl]cyclohexanecarboxamide
    • UNII-MD6P741W8A
    • GTPL803
    • 2414315-81-2
    • HSDB 8021
    • UK-427,857 maraviroc (MVC)
    • GTPL806
    • 4,4-difluoro-N-((1S)-3-((1R,5S)-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl)-1-phenylpropyl)cyclohexanecarboxamide
    • 4,4-difluoro-N-((S)-3-((1S,3S,5R)-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-aza-bicyclo[3.2.1]octan-8-yl)-1-phenylpropyl)cyclohexanecarboxamide
    • 4,4-difluoro-N-{(1S)-3-[(3-exo)-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl}cyclohexanecarboxamide
    • NCGC00183109-01
    • SMR004703532
    • 4,4-difluoro-N-((1S)-3-(3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl)-1-phenylpropyl)cyclohexanecarboxamide
    • CHEBI:63608
    • MARAVIROC [ORANGE BOOK]
    • Celsentri , UK-427857 , Selzentry
    • 4,4-difluoro-N-[(1S)-3-[(1R,3S,5S)-3-(3-isopropyl-5-methyl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide
    • MDL: MFCD13188530
    • Inchi: 1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1
    • InChI Key: GSNHKUDZZFZSJB-HLMSNRGBSA-N
    • SMILES: FC1(CCC(CC1)C(N[C@H](C1C=CC=CC=1)CCN1[C@H]2CC[C@@H]1CC(C2)N1C(C)=NN=C1C(C)C)=O)F

Computed Properties

  • Exact Mass: 513.32800
  • Monoisotopic Mass: 513.328
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 6
  • Heavy Atom Count: 37
  • Rotatable Bond Count: 8
  • Complexity: 751
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 3
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Surface Charge: 0
  • Tautomer Count: 2
  • XLogP3: 5.1
  • Topological Polar Surface Area: 63

Experimental Properties

  • Color/Form: Brown solid
  • Density: 1.29
  • Melting Point: 79-81°C
  • Refractive Index: 1.627
  • Solubility: DMSO: >30mg/mL
  • PSA: 63.05000
  • LogP: 6.27970
  • pka: 7.3(at 25℃)
  • Optical Activity: [α]-15/D

Maraviroc Security Information

  • Signal Word:Warning
  • Hazard Statement: H302
  • Warning Statement: P280-P305+P351+P338
  • Hazardous Material transportation number:NONH for all modes of transport
  • WGK Germany:1
  • Hazard Category Code: 48/22
  • Safety Instruction: 22-36
  • Hazardous Material Identification: Xn
  • Storage Condition:Powder -20°C 3 years ? 4°C 2 years In solvent -80°C 6 months ? -20°C 1 month

Maraviroc Customs Data

  • HS CODE:2934999090
  • Customs Data:

    China Customs Code:

    2934999090

    Overview:

    2934999090. Other heterocyclic compounds. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%

    Declaration elements:

    Product Name, component content, use to

    Summary:

    2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

Maraviroc Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-QG826-10mg
Maraviroc
376348-65-1 99+%
10mg
1142CNY 2021-05-08
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-QG826-5mg
Maraviroc
376348-65-1 99+%
5mg
698CNY 2021-05-08
SHANG HAI XIAN DING Biotechnology Co., Ltd.
B-QG826-50mg
Maraviroc
376348-65-1 99+%
50mg
4414CNY 2021-05-08
TRC
M193000-5mg
Maraviroc
376348-65-1
5mg
$64.00 2023-05-18
TRC
M193000-10mg
Maraviroc
376348-65-1
10mg
$ 115.00 2023-09-07
TRC
M193000-25mg
Maraviroc
376348-65-1
25mg
$ 195.00 2023-09-07
TRC
M193000-50mg
Maraviroc
376348-65-1
50mg
$ 362.00 2023-09-07
TRC
M193000-100mg
Maraviroc
376348-65-1
100mg
$656.00 2023-05-18
WU HAN AN JIE KAI Biomedical Technology Co., Ltd.
ajci14422-5mg
Maraviroc
376348-65-1 98%
5mg
¥441.00 2023-09-09
WU HAN AN JIE KAI Biomedical Technology Co., Ltd.
ajci14422-25mg
Maraviroc
376348-65-1 98%
25mg
¥1692.00 2023-09-09

Maraviroc Suppliers

Amadis Chemical Company Limited
Gold Member
Audited Supplier Audited Supplier
(CAS:376348-65-1)Maraviroc
Order Number:A823806
Stock Status:in Stock
Quantity:1g/250mg/100mg
Purity:99%
Pricing Information Last Updated:Friday, 30 August 2024 05:18
Price ($):794.0/292.0/174.0
Recommended suppliers
Amadis Chemical Company Limited
(CAS:376348-65-1)Maraviroc
A823806
Purity:99%/99%/99%
Quantity:1g/250mg/100mg
Price ($):794.0/292.0/174.0
Email